BTI
PRCT icon

Blue Trust Inc’s Procept Biorobotics PRCT Stock Holding History

Blue Trust Inc’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,855
Closed -$341K – 2638
2025
Q4 		$341K Buy
10,855
+2,525
+30% +$83.7K ﹤0.01% 611
2025
Q3 		$297K Buy
8,330
+2,378
+40% +$109K ﹤0.01% 668
2025
Q2 		$343K Buy
5,952
+956
+19% +$54.1K ﹤0.01% 587
2025
Q1 		$291K Buy
4,996
+1,118
+29% +$76.3K ﹤0.01% 575
2024
Q4 		$312K Sell
3,878
-563
-13% -$48.1K ﹤0.01% 518
2024
Q3 		$271K Buy
4,441
+466
+12% +$33.1K ﹤0.01% 721
2024
Q2 		$196K Hold
3,975
– – ﹤0.01% 713
2024
Q1 		$196K Buy
3,975
+1,346
+51% +$64.1K ﹤0.01% 510
2023
Q4 		$86K Buy
2,629
+620
+31% +$21.1K ﹤0.01% 746
2023
Q3 		$71K Buy
+2,009
New +$68.5K ﹤0.01% 738

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Blue Trust Inc's PRCT Position: Q1 2026 in Review

Blue Trust Inc sold out of Procept Biorobotics (PRCT) in Q1 2026, closing a stake of 10,855 shares — an estimated $341K sold.

Blue Trust Inc first reported a position in PRCT in Q3 2023 and held it in 10 quarters. The position peaked at $343K in Q2 2025. 257 funds tracked by Wall St. Rank hold PRCT as of Q1 2026.

  • Blue Trust Inc reported no remaining Procept Biorobotics position as of Q1 2026 after selling out during the quarter.
  • Blue Trust Inc sold 10,855 Procept Biorobotics shares in Q1 2026, an estimated $341K.
  • Blue Trust Inc first reported a position in Procept Biorobotics in Q3 2023 and held it in 10 quarters.
  • Blue Trust Inc's Procept Biorobotics position peaked at $343K in Q2 2025.
  • 257 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2026.

Based on Blue Trust Inc's 13F filing for Q1 2026, filed 20 Apr 2026.